IRVINE, Calif., March 21 /PRNewswire/ -- Numira Biosciences today announced that the company has secured $2.5 million in a Series A round of funding led by vSpring Capital. The financing also included the participation of the Tech Coast Angels and the Pasadena Angels, both leading angel investor groups based in Southern California.
“There could not have been a more favorable outcome to our fund raising efforts than the response and interest expressed by our investors,” stated Michael Beeuwsaert, President and CEO, Numira Biosciences. “The completion of this financing is a strong endorsement of Numira’s technologies and signals an important step in the company’s growth. These new resources will enable the company to expand its operations and further develop and commercialize its products and services.”
“vSpring is very excited about Numira’s technologies and their applications in the drug development market,” commented Dr. Dinesh Patel, a founding managing director of vSpring Capital. “We look forward to working with Numira and its management to further develop its promising pipeline of products, software and services.”
About Numira Biosciences:
Numira is a specialty R&D tools company focused on leveraging advances in genetics and molecular imaging to create a catalog of novel, high-value products that provide researchers with unprecedented insight into genomics, developmental biology, mechanisms of disease, drug efficacy and toxicity.
About vSpring Capital:
vSpring Capital, an early-stage venture firm headquartered in Salt Lake City, focuses on investment opportunities in information technology and life sciences. vSpring capitalizes on the managerial skills and operating experience of its principals to successfully invest in and mentor early stage companies. For more information, visit www.vspring.com.
About Tech Coast Angels:
Tech Coast Angels is the largest angel investor network in the United States, and provides funding and guidance to more early-stage, high-growth companies in Southern California than any other venture capital, angel or other private equity group. For more information, visit www.techcoastangels.com.
About Pasadena Angels:
Founded in 2000, the Pasadena Angels is a group of over 100 leading private investors that provide long-term human and financial capital to help build successful companies. The Pasadena Angels invests in early stage companies in a broad range of industries that have the potential to build sustainable and successful businesses. For more information, visit www.pasadenaangels.com.
For more information, please visit www.numirabio.com.
Numira Biosciences Inc.
CONTACT: Michael Beeuwsaert, President & CEO of Numira Biosciences Inc.,+1-949-623-8603, mbeeuwsaert@numirabio.com
Web site: http://www.numirabio.com/
